LexDanaLexDanabeta
Inventor

Adam R. Mezo

Inventor
Waltham, MA, US

Overview

23→
Patents
2008–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C12NMicroorganisms or enzymes15%
C12YEnzymes11%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
PatentTitleYear
11,084,866Immunoglobulin chimeric monomer-dimer hybrids202110,597,436Acylated insulin compound202010,588,935FC receptor (FcRn) binding peptides and uses thereof202010,513,551Immunoglobulin chimeric monomer-dimer hybrids201910,400,021Acylated insulin compound201910,287,564Procoagulant compounds201910,046,023FC receptor (FcRn) binding peptides and uses thereof20189,938,335Glucagon and GLP-1 co-agonist compounds20189,725,496'Immunoglobulin chimeric monomer-dimer hybrids'20179,636,416'Immunoglobulin chimeric monomer-dimer hybrids'20179,527,890'FC receptor (FcRn) binding peptides and uses thereof'20169,486,507'Pro-coagulant compounds and methods of use thereof'20169,012,603'Peptides that block the binding of IgG to FcRn'20158,932,830'Immunoglobulin chimeric monomer-dimer hybrids'20158,906,844'Immunomodulatory peptides'20148,900,827'Immunoglobulin chimeric monomer-dimer hybrids'20148,329,182'Immunoglobulin chimeric monomer-dimer hybrids'20128,101,186'Peptides that block the binding of IgG to FcRn'20127,862,820'Immunoglobulin chimeric monomer-dimer hybrids'20117,820,162'Methods for chemically synthesizing immunoglobulin chimeric proteins'20107,404,956'Immunoglobulin chimeric monomer-dimer hybrids'20087,381,408'Methods for chemically synthesizing immunoglobulin chimeric proteins'20087,348,004'Immunoglobulin chimeric monomer-dimer hybrids'2008

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2008–2012Patents assigned to SYNTONIX PHARMACEUTICALS INC (7)· patent assignee history
2008–2021Based in Waltham, MA, US· patent location history
2012–2016Patents assigned to MEZO ADAM R (5)· patent assignee history
2014–2015Patents assigned to BIOGEN IDEC HEMOPHILIA INC (3)· patent assignee history
2014–2016Based in Needham, MA, US· patent location history
2016–2020Patents assigned to BIOGEN MA INC (3)· patent assignee history
2016–2020Based in Carmel, IN, US· patent location history
2017–2019Patents assigned to BIOVERATIV THERAPEUTICS INC (3)· patent assignee history
2019–2020Based in San Diego, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SYNTONIX PHARMACEUTICALS INC72008–2012
MEZO ADAM Rself52012–2016
BIOGEN IDEC HEMOPHILIA INC32014–2015
BIOGEN MA INC32016–2020
BIOVERATIV THERAPEUTICS INC32017–2019
Locations
LocationPatentsSpan
Waltham, Massachusetts, US142008–2021
Carmel, IN, US52016–2020
San Diego, California, US22019–2020
Needham, Massachusetts, US22014–2016